Ann: SPL receives positive FDA feedback on DEP SN38 for PROC, page-9

Yes @Teddyward no one wants to talk about funding ... lol

It may expedite a license deal that may see funding from same but it is likely months away while they sort out trial design etc - let's just hope there is a decent upfront payment when they sign this agreement, given that hasn't been a strong point in previous Starpharma negotiations / agreements

Even if the trial goes well and demonstrates efficacy, it's still a few years away from an NDA submission / FDA approval though however it can be rewarding when it happens like Mesoblast holders are experiencing today